October 2016

Letter from the Editor

October 1, 2016

Clinical Data in Real Time The number of clinical trials using mobile apps more than doubled, rising from 135 in 2014 to 300 in 2015, according to the IMS Health Study Patient Options Expand as Mobile Healthcare Apps Address Wellness and Chronic Disease Treatment Needs. No doubt when 2016 numbers are crunched, we will see […]

Upfront

October 1, 2016

Industry at Large BMS Employees Cycle Coast to Coast to Raise Money for Cancer Research The first of six teams of Bristol-Myers Squibb oncology employees set out in September from Cannon Beach on the Oregon coast on the first leg of the 2016 Coast 2 Coast 4 Cancer Ride, a 21-day cycling ride that brings […]

Innovator’s Corner

October 1, 2016

A New Era for “Bubble Boy” Disease Sven Kili, M.D., head of gene therapy development at GlaxoSmithKline, talks about the company’s gene therapy to treat a very rare immune system disorder, which recently received EU approval. Children born with a specific immune disorder — severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), sometimes called […]

mHealth

October 1, 2016

Novartis Niji System May Provide Earlier Diagnosis of Severe Allergic Asthma Trending Now:  Point-of-care testing is gaining significance. Novartis has unveiled a novel in-office point-of-care diagnostic tool: the Niji System and Total IgE Test. This first-ever test delivers quantitative total IgE (Immunoglobulin E) levels in about 12 minutes using only one to two droplets of […]

Pharma Trax

October 1, 2016

High-value Specialty Medicines are Driving Growth in the Generics Market Trending now:  Emerging markets are the next big opportunity after the United States. Increased life expectancy, a growing older-population cohort, and the higher incidence of chronic lifestyle-related diseases are encouraging the use of generic pharmaceuticals as governments and healthcare service providers strive to contain costs. […]

Tools of the Trade

October 1, 2016

Medidata Introduces Payment Technology for Clinical Trial Sites  Trending Now:  The market’s first end-to-end cloud-based reimbursement tool uses clinical trial data to calculate costs and disburse payment to investigative sites in real time. Medidata has launched Medidata Payments. A new component of the Medidata Clinical Cloud, Medidata Payments enables clinical trial sponsors and contract research […]

What’s New

October 1, 2016

Biomedical Literature Product Released Trending now: AI Platform Forms Basis for Discovery Tool Quertle LLC, a developer of the first artificial intelligence (AI) biomedical big data platform (BioAI), has released Qinsight. The product uses BioAI’s neural networks and other AI methods, along with visual analytics to enable high-efficiency discovery and insight from the biomedical literature. […]

The Calendar

October 1, 2016

Coming Attractions The Global Site Solutions Summit, produced by the Society for Clinical Research Sites (SCRS), is committed to being “the site’s meeting.” The conference provides a unique hub where sites, sponsors, CRO executives, and regulators come together and share best practices; build their businesses; and develop new partnerships through debates, ideation sessions, workshops, and […]

Talent Pool

October 1, 2016

Pharma pool John Demaree Astellas Promotes VP of Oncology Marketing in the Americas Region Astellas has promoted John Demaree to VP, oncology marketing, Astellas Americas. In this role, Mr. Demaree is leading Astellas’ oncology marketing team in promotion of in-market products, preparation for new oncology product launches and strategic planning and collaboration with the company’s […]

Last Word

October 1, 2016

Providing Global Access Isabel Torres, Global Head, Access to Medicines Initiative, Takeda, talks about the company’s strategy for providing access to its medicines in less developed healthcare systems. PV: What is your vision for the Access to Medicines Initiative? Torres: We wanted to expand our already existing commitment to global health. The idea is to […]

mHealth in Clinical Research

October 1, 2016

Mobile technology could revolutionize clinical research. Sensors, wearable devices, and mobile apps have the potential to offer pharmaceutical sponsors access to patient data that complement existing data and provide a more complete view of safety and efficacy. The number of U.S. consumers who use wearables and mobile apps for managing their health has doubled in […]

The Specialty Drug Market

October 1, 2016

As specialty drugs continue to earn a greater share of the pharmaceutical market, marketing, sales, and key opinion leader (KOL) professionals are faced with addressing market access issues, while needing to create an attractive value proposition for physicians.  Going forward, these roles will expand to include responsibilities related to education, reimbursement knowledge, and services that […]

Advertising to the Masses

October 1, 2016

Earlier this year, eMarketer predicted that digital ad spending across all industries would surpass TV for the first time in 2017. Overall, TV ad spending will total $72.01 billion, or 35.8% of total media ad spending; digital ad spending in 2017 will equal $77.37 billion, or 38.4% of total ad spending. But these rising digital […]

The Evolution of Patient Communities

October 1, 2016

Patient and community outreach have changed over the last decade. Patient organizations and pharmaceutical companies have been building communities, especially online communities of patients, because they recognize the opportunity to provide support and information exchange. Social media has had a huge impact on patient communities. Patients use the Internet and social media as a way […]

French Connection: Picture of an Evolving Market

October 1, 2016

France is the second-largest European market and one of the world’s largest consumers of pharmaceutical products. The French pharmaceutical industry grew by 17.9% between 2000 and 2010, compared with growth of 6.1% in the manufacturing sector. This performance can be explained by solid scientific, industrial and economic advantages, and by the dynamism of its players […]

SHOWCASE FEATURE: Patient Solutions: Patients Are No Longer Patient for Solutions

October 1, 2016

Over the past few years, the term patient-centric has been used so frequently that it almost has no meaning. But despite the centricity over the concept, the strategy of putting patients squarely in the middle of what the industry is doing and where it needs to go is sound. In parallel, the concept of patient […]

Helping Patients Help Themselves

October 1, 2016

One of the biggest challenges in healthcare begins the moment a patient steps out of the doctor’s office or clinic. Suddenly, that individual assumes the bulk of responsibility for managing his or her condition on a daily basis — day after day, good mood or bad, on vacations, at work and at home. Managing a […]

Creating a More Efficient, Effective, and Easier Model for Patient Care

October 1, 2016

It’s a challenge that continues to keep many pharmaceutical leaders up at night: how to advance patient-oriented programs in an industry addicted to the use of middlemen. A myriad of players, including PBMs (pharmacy benefit managers), wholesalers, specialty pharmacies, and other “hub” service companies are focused on disparate priorities often rife with inherent conflicts of […]

Addressing Whole Patient Needs: A New Model for Pharma

October 1, 2016

In today’s healthcare environment, there is more pressure to deliver optimal patient outcomes with greater efficiency. Traditional marketing approaches that rely on messaging to promote patient acceptance of therapy and adherence are not enough to drive real-world impact. To stay relevant, the pharmaceutical industry needs to find ways to deliver solutions that go beyond driving […]

Not “Patients,” But People

October 1, 2016

Finding Inspiration on Customer-Centric Marketing From Other Walks of Life Let’s not be healthcare marketers for a moment. Let’s be us: men, women, parents, grandparents, grandchildren, children, aunts, uncles, even pet parents. Sometimes we get sick. Our loved ones may suffer a heart attack. Alzheimer’s. Osteoporosis. RA. Cancer. Our employer-sponsored healthcare plans have higher deductibles, […]

Personal Patient Connections Generate Real-world Results

October 1, 2016

In today’s plugged in, non-stop digital world, pharma brands are finding that helping patients create a personal, ongoing connection with a healthcare professional is a core catalyst for adherence to therapy, a more satisfying patient journey, brand loyalty, and — ultimately — improved patient outcomes. Mounting evidence supports the value of a personalized, patient-focused approach, […]

SHOWCASE FEATURE: Supply Chain: The Pharma Supply Chain

October 1, 2016

The pharmaceutical supply chain is a complex system through which prescription medicines, biologics, and devices are delivered to patients. The Kaiser Family Foundation lays out the distribution channel as such: products originate in manufacturing sites, they are then transferred to wholesale distributors. These products are then stocked at retail, mail-order, and other types of pharmacies. […]

Key Questions to Ask When making Critical Channel Decisions

October 1, 2016

As the process of bringing new products to market has become increasingly complex, so too have decisions around distribution and channel strategy. When thinking about how to get products into the hands of providers and patients in the right place and at the right time, pharmaceutical companies have a myriad of options to consider beyond […]

Speak Out

October 1, 2016

Including the Elderly in Clinical Trials: A Challenge for the Ages, Solutions for Today Provided by: Artcraft Health Written by: Allison Musante, ELS Allison Musante is a copywriter and editor at Artcraft Health, a full-service health education and marketing communications agency. She has served at the helm of two peer-reviewed journals of the American Geriatrics […]

FEEDBACK